A carregar...
Protein Kinase Cδ is a downstream effector of oncogenic KRAS in lung tumors(1)
Oncogenic activation of KRAS occurs commonly in non-small cell lung cancer (NSCLC), but strategies to therapeutically target this pathway have been challenging to develop. Information about downstream effectors of KRAS remains incomplete and tractable targets are yet to be defined. In this study we...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3271733/ https://ncbi.nlm.nih.gov/pubmed/21335545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1511 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|